Aster Dm Quality Care Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aster DM Quality Care Ltd is ₹ 645 as of 23 Oct 15:30 . The P/E Ratio of Aster DM Quality Care Ltd changed from 46.2 on March 2021 to 89.7 on March 2026 . This represents a CAGR of 11.69% over 6 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Aster DM Quality Care Ltd changed from ₹ 6858 crore on March 2021 to ₹ 34794 crore on March 2026 . This represents a CAGR of 31.08% over 6 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Aster DM Quality Care Ltd for the Jun '26 is ₹ 1347 crore as compare to the Mar '26 revenue of ₹ 1218 crore. This represent the growth of 10.57% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Aster DM Quality Care Ltd for the Jun '26 is ₹ 178.58 crore as compare to the Mar '26 ebitda of ₹ 260.58 crore. This represent the decline of -31.47% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Aster DM Quality Care Ltd changed from ₹ 5152 crore to ₹ 29.28 crore over 9 quarters. This represents a CAGR of -89.95% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Aster DM Quality Care Ltd changed from 3818 % on March 2024 to 58.04 % on March 2026 . This represents a CAGR of -75.23% over 3 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aster DM Healthcare Ltd

Aster DM Healthcare Limited was erstwhile established as 'Aster DM Healthcare Private Limited', a private limited company on 18 January, 2008.
On November 29, 2013.
The Company was converted into a public limited company and the name of the Company was changed to Aster DM Healthcare Limited. Aster DM Healthcare Limited is one of the leading healthcare player in the GCC and India.
Founded in 1987 by Dr. Azad Moopen, the Company has emerged as an integrated healthcare service organization that provides the complete circle of care to people through network of hospitals, clinics, labs and pharmacies, providing primary, secondary, tertiary to quaternary care to all segments of the population. Aster DM offer a diverse portfolio of specialised brands that serve patients in Primary, Secondary, Tertiary, and Quaternary Care, Healthcare Retailing, Diagnostic Laboratories, Digital Health, and Medical Education.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Aster DM Quality Care Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Aster DM Healthcare Ltd or Transgene Biotek Ltd?

Market cap of Aster DM Healthcare Ltd is 56,222 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Aster DM Healthcare Ltd and Transgene Biotek Ltd?

The stock performance of Aster DM Healthcare Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aster DM Healthcare Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the Aster DM Healthcare Ltd stock price is INR ₹645.0. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Aster DM Healthcare Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Aster DM Healthcare Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.